Thomas Celona - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Thomas Celona's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Thomas Celona

Thomas Celona

Verified

Associate Editor, Cancer Today

Philadelphia

Final Covers

public health and sanitation cybersecurityeducation transportation and disinformation

Doesn’t Cover

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 270

  • March 28: The Week in Cancer News

    By Thomas Celona Verified

    Mar. 28, 2025

  • Cancer Today’s Spring 2025 Issue: How Liquid Biopsies Can Guide Treatment Decisions, Extending Survival in Treatment-resistant Breast Cancer, and More

    By Thomas Celona Verified

    Mar. 20, 2025

  • March 28: The Week in Cancer News

    By Thomas Celona Verified

    Mar. 28, 2025

As seen in

Company Info

Cancer Today

Published quarterly by the American Association for Cancer Research, Cancer Today is the authoritative resource for cancer patients, survivors, and their family members and friends. In every issue, Cancer Today offers information and inspiration as you face the challenges of diagnosis, treatment, survivorship or caregiving.‬ Cancer Today is the authoritative resource for cancer patients, survivors and caregivers who are seeking information and inspiration as they or their loved ones face diagnosis, treatment and life after cancer. Cancer Today guides readers through every step of the cancer journey, empowering them with reliable reporting on the latest advances in cancer research; insider looks at the people driving progress against cancer; practical advice for living life as a cancer patient or survivor; guidance on being an active partner in one's treatment; candid stories about how patients, survivors and caregivers are dealing with the disease; and thoughtful examination of efforts to overcome obstacles to quality cancer care and quality of life.‬

, ,

'+1 215-440-9300

Founded: 1996